TANOVEA®-CA1 (rabacfosadine for injection), 4 single use vials
CONTAINS 4 SINGLE USE VIALS.
Each vial contains 16.4 mg of rabacfosadine.
Conditionally approved by FDA pending a full demonstration of effectiveness under application number 141-475
Indication: For the treatment of lymphoma in dogs
Caution: Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. Use only as directed. It is a violation of Federal law to use this product other than as directed in the labeling.